BRIEF-LifeMd To Offer Market-Leading Pricing For Glp-1 Medications Wegovy And Ozempic In Continued Collaboration With Novo Nordisk

Reuters
Nov 17, 2025
BRIEF-LifeMd To Offer Market-Leading Pricing For Glp-1 Medications Wegovy And Ozempic In Continued Collaboration With <a href="https://laohu8.com/S/NVO">Novo Nordisk</a>

Nov 17 (Reuters) - LifeMD Inc LFMD.O:

  • LIFEMD® TO OFFER MARKET-LEADING PRICING FOR GLP-1 MEDICATIONS WEGOVY® AND OZEMPIC® IN CONTINUED COLLABORATION WITH NOVO NORDISK

  • LIFEMD INC - OFFERS GLP-1 MEDICATIONS AT $199 PER MONTH

Source text: ID:nGNXbdRrtY

Further company coverage: LFMD.O

((Reuters.Briefs@thomsonreuters.com;))

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10